Quick Answer
GeneDx Holdings Corp. reported Stockholders Equity of $308.18 million for fiscal year 2025.
GeneDx Holdings Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $308.18M | +25.7% |
| 2024 | $245.25M | +7.6% |
| 2023 | $228.02M | -10.1% |
| 2022 | $253.71M | -34.6% |
| 2021 | $388.10M | -0.7% |
| 2021 | $391.02M | +169.0% |
| 2021 | -$566.50M | -8.6% |
| 2021 | -$521.83M | -58.1% |
| 2020 | -$330.05M | -272.1% |
| 2019 | -$88.71M | -58.5% |
| 2018 | -$55.97M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $292.26M | +42.9% | +5.5% |
| June 30, 2025 | $277.13M | +42.8% | +7.7% |
| March 31, 2025 | $257.40M | +24.2% | +5.0% |
| December 31, 2024 | $245.25M | +7.6% | +19.9% |
| September 30, 2024 | $204.50M | -19.6% | +5.4% |
| June 30, 2024 | $194.04M | -34.5% | -6.4% |
| March 31, 2024 | $207.22M | -36.9% | -9.1% |
| December 31, 2023 | $228.02M | -10.1% | -10.3% |
- GeneDx Holdings Corp. showed an increase of +25.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, GeneDx Holdings Corp.’s stockholders equity has grown by 650.6% (from -$55.97 million to $308.18 million).
- The most recent figure is from GeneDx Holdings Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: